Global Healthcare Contract Development and Manufacturing Organization Market Grows Steadily at a CAGR of 8.86%

Contract manufacturing organizations (CMOs), also known as contract development and manufacturing organizations (CDMOs), are businesses that provide contract services to other organizations in the pharmaceutical and healthcare industries. CDMOs aid healthcare providers in the development of new pharmaceuticals. Service providers aim to deliver end-to-end consistency and efficiency for all outsourcing clients while specializing in a specific technology or dosage form. Contract manufacturing organizations (CMOs) are reliable because they are compliant, have a skilled workforce, have access to cutting-edge equipment, and have reasonable prices across their service offerings.

Market Dynamics

Increasing Outsourcing Services by Pharmaceutical Companies Drives the Global Market

Many pharmaceutical firms have enlisted CMOS, CROs, and CDMOs to aid in the pre-formulation, development, and manufacturing of cutting-edge new medications. Typically, it is the smaller and medium-sized biopharmaceutical firms that lead the way in developing new drugs. Due to their high-profit margins, these businesses are easy prey for hospitals and other healthcare organizations looking to cut costs. Medical device outsourcing in developing countries like India and China is expected to grow for several reasons, including increased cost-cutting measures adopted by OEMs in response to budget scrutiny in developed countries, changes in reimbursement schemes, and pricing pressure. Businesses in the medical device industry are increasingly looking to develop nations to expand into new customer bases and revenue streams.

Rising Incidence of Cardiovascular Diseases Creates Tremendous Opportunities

Around 17.9 million people annually lose their lives due to cardiovascular diseases (CVDs), making them the leading cause of death worldwide. It is possible to reduce the number of premature deaths caused by CVDs by identifying those at the highest risk and ensuring they receive treatment. All primary healthcare facilities must access medicines and essential health technologies for noncommunicable diseases so those in need can receive therapy and counseling. As the prevalence of heart disease and related illnesses rises, so does the demand for cardiovascular devices, increasing the outsourcing of these products. There is an increase in the outsourcing of cardiovascular devices because of their high complexity and the need for technical expertise.

Regional Analysis

North America is the most significant shareholder in the global healthcare contract development and manufacturing organization market and is expected to grow at a CAGR of 8.72% during the forecast period. North America is home to many well-established biotechnologies and pharmaceutical and medical device companies. Also, as companies in the life sciences and pharmaceutical industries spend more on research and development, they will likely need more contract manufacturing in the region. During the time frame of the forecast, the market is likely to benefit from the development of medical device equipment that is less expensive. Also, medical device makers focus on North America because its healthcare industry is increasing.

Asia-Pacific is expected to grow at a CAGR of 9.57%, generating USD 125.0814 billion during the forecast period. During the projected period, the market is likely to be driven by a rise in the number of elderly adults and an increase in the use of medical devices in developing countries like India and China. India has become a very profitable market in South Asia because there are so many CMOs and CDMOs in the country. Many new firms are entering the market for producing personal care items, so this figure is constantly rising. India's low manufacturing costs can be attributed to the country's plentiful cheap labor and relatively inexpensive infrastructure. Since India is a leading producer of raw materials, it is an attractive option for contract manufacturing. The development of the pharmaceutical industry in China, India, and Japan is expected to affect the market in the coming years positively.

Potentially disruptive changes to the EU's regulatory framework could make entering or exiting the market more difficult. Due to the region's strict regulatory policies, the contract development and manufacturing organization market is predicted to expand profitably. The United Kingdom is a significant European market for pharmaceuticals and medical equipment. Growth is expected to be aided by numerous multinational CDMOs operating within the country. Healthcare in Spain is provided to all residents at no cost. The rising national patient population has increased the need for medical supplies. The market is expected to grow as the number of factories in the country continues to rise.

Key Highlights

• The global healthcare contract development and manufacturing organization market was valued at USD 221.97 billion in 2021. It is projected to reach USD 476.55 billion by 2030, growing at a CAGR of 8.86% during the forecast period (2022–2030).
• Based on services, the global healthcare contract development and manufacturing organization market is bifurcated into contract development and contract manufacturing. The contract manufacturing segment is the highest contributor to the market and is expected to grow at a CAGR of 8.79% during the forecast period.
• North America is the most significant shareholder in the global healthcare contract development and manufacturing organization market and is expected to grow at a CAGR of 8.72% during the forecast period.

Market Segments

Global Healthcare Contract Development and Manufacturing Organization Market: Segmentation

By Service

• Contract Development
• Contract Manufacturing

By Regions

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East and Africa